Indication

Acute streptococcal epiglottitis

Acute streptococcal epiglottitis is a rapidly progressive, life-threatening bacterial infection of the supraglottic airway structures—principally involving the epiglottis, aryepiglottic folds, and surrounding tissues—caused by *Streptococcus* species, most commonly *Streptococcus pneumoniae* or group A beta-hemolytic streptococci. Read more about Acute streptococcal epiglottitis

23 drugs 21 manufacturers

Advertisement

Drugs that treat it

Common Acute streptococcal epiglottitis therapies.

Showing 1–9 of 23 drugs

Filter & compare in the drug finder →Opens the drug finder with Acute streptococcal epiglottitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acute streptococcal epiglottitis.

Acute streptococcal epiglottitis is a rapidly progressive, life-threatening bacterial infection of the supraglottic airway structures—principally involving the epiglottis, aryepiglottic folds, and surrounding tissues—caused by *Streptococcus* species, most commonly *Streptococcus pneumoniae* or group A beta-hemolytic streptococci.

While historically pediatric, it now presents predominantly in adults as well as unvaccinated or partially vaccinated children following widespread *Haemophilus influenzae* type b immunization.

The condition is pathologically defined by severe localized cellulitis and marked inflammatory edema that can swiftly precipitate critical upper airway obstruction, clinically manifesting with high fever, severe sore throat, odynophagia, drooling, dyspnea, and inspiratory stridor.

Personalize your experience

Follow Acute streptococcal epiglottitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it